---
schema_version: "secwatch.filing_event.v1"
accession: "0001568651-22-000054"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2022-11-08T23:59:59+00:00"
generated_at: "2026-06-22T03:35:33.733662+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Oscar Health Q3: Net loss $194M, membership up 81%; CFO transition announced, targets 2024 profitability

## Summary
- Membership of 1,075,445 as of Sep 30, 2022, up 81% YoY; premiums earned $954M, up 116% YoY.
- Net loss of $194M improved $18M YoY; Adjusted EBITDA loss of $160M improved $28M YoY.
- Medical Loss Ratio improved 980 bps to 89.9%; InsuranceCo Combined Ratio improved 1,220 bps to 110.6%.
- FY2022 guidance updated: Direct and Assumed Policy Premiums $6.7-6.9B; Adjusted EBITDA loss modestly above $480M high-end.
- CFO R. Scott Blackley transitions to Chief Transformation Officer; Sid Sankaran returns as Interim CFO effective Dec 1, 2022.

## SEC filing metadata
- accession: 0001568651-22-000054
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2022-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000156865122000054/0001568651-22-000054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000156865122000054/oscr-20221108.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001568651-22-000054
- JSON: https://secwatch.observer/filing/0001568651-22-000054.json
- Plain text: https://secwatch.observer/filing/0001568651-22-000054.txt

## Key facts
- Earnings Releases
  Oscar Health, Inc. updated its the third quarter ended September 30, 2022 guidance (reaffirmed).
  - Period: the third quarter ended September 30, 2022
  - Guidance: reaffirmed
  - Result: reported results
  source text: On November 8 , 2022, Oscar Health, Inc. (the “Company”), announced the Company’s financial results for the quarter ended September 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000156865122000054/0001568651-22-000054-index.htm
- Earnings Releases
  Oscar Health, Inc. updated its Full Year 2022 guidance (reaffirmed).
  - Period: Full Year 2022
  - Guidance: reaffirmed
  - Result: guidance update
  source text: Oscar is updating its FY22 outlook to reflect the impact of higher membership.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000156865122000054/0001568651-22-000054-index.htm
- Executive change
  R. Scott Blackley was appointed as Chief Transformation Officer at Oscar Health, Inc..
  - Action: appointed
  - Role: Chief Transformation Officer
  source text: On November 7, 2022, the Board of Directors of the Company (the “Board”) appointed R. Scott Blackley as the Chief Transformation Officer of the Company and Siddhartha Sankaran as Interim Chief Financial Officer of the Company, each effective December 1, 2022 (the “Transition Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000156865122000054/0001568651-22-000054-index.htm
- Executive change
  Siddhartha Sankaran was appointed as Interim Chief Financial Officer at Oscar Health, Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: On November 7, 2022, the Board of Directors of the Company (the “Board”) appointed R. Scott Blackley as the Chief Transformation Officer of the Company and Siddhartha Sankaran as Interim Chief Financial Officer of the Company, each effective December 1, 2022 (the “Transition Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000156865122000054/0001568651-22-000054-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.